Sanofi (SNY) Raw Materials (2015 - 2018)

Sanofi (SNY) posted Raw Materials of $1.2 billion for Q4 2018, up 2.38% sequentially from $1.1 billion in Q4 2017, and up 2.38% YoY from $1.1 billion in Q4 2017.

Sanofi (SNY) Raw Materials (2015 - 2018) Analysis & Trends

Sanofi (SNY) has 4 years of Raw Materials data on file, last reported at $1.2 billion in Q4 2018.

  • Quarterly Raw Materials rose 2.38% year-over-year to $1.2 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $1.2 billion (up 2.38% YoY) and the FY2018 annual result came in at $1.2 billion, up 6.74% from the prior year.
  • Raw Materials grew to $1.2 billion in Q4 2018 per SNY's latest filing, from $1.1 billion in the prior quarter.
  • The five-year high for Raw Materials was $1.2 billion in Q4 2018, with the low at $1.0 billion in Q4 2016.
  • Average Raw Materials over 4 years is $1.1 billion, with a median of $1.1 billion recorded in 2015.
  • Year-over-year, Raw Materials decreased 2.62% in 2016 and rose 10.54% in 2017.
  • Sanofi's Raw Materials stood at $1.1 billion in 2015, then slipped by 2.62% to $1.0 billion in 2016, then climbed by 10.54% to $1.1 billion in 2017, then increased by 2.38% to $1.2 billion in 2018.
  • Business Quant data shows SNY's Raw Materials at $1.2 billion in Q4 2018, $1.1 billion in Q4 2017, and $1.0 billion in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Sanofi - - 9.49 Bn

Historic Data

Download Data
DateValue
Dec 31, 2018 1.16 Bn
Dec 31, 2017 1.13 Bn
Dec 31, 2016 1.02 Bn
Dec 31, 2015 1.05 Bn